...
首页> 外文期刊>RSC Advances >Interactions between sirtuins and fluorogenic small-molecule substrates offer insights into inhibitor design
【24h】

Interactions between sirtuins and fluorogenic small-molecule substrates offer insights into inhibitor design

机译:沉默调节蛋白与荧光小分子底物之间的相互作用为抑制剂设计提供了见识

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Sirtuins are nicotinamide adenine dinucleotide (NAD+)-dependent lysine deacylases regulating metabolism and stress responses and are involved in human pathologies such as neurodegeneration. In this study, four fluorogenic small-molecule substrates, i.e., acetyl-(AcBKA), crotonyl-(CrBKA), succinyl-(SuBKA), and myristoyl-(MyBKA)-containing substrates, were synthesized and tested against three representative sirtuin isoforms (i.e., SIRT2, SIRT5, and SIRT6). Enzyme kinetic results indicate that the fluorogenic small-molecule substrates have similar sirtuin-isoform preference as compared to peptide substrates. ITC analyses reveal that AcBKA or MyBKA binding to SIRT2 is mainly driven by entropy, whereas SuBKA binding to SIRT5 is driven by enthalpy. The SIRT5:SuBKA complex crystal structure reveals a new substrate-binding mode that is different from peptide substrate binding modes, but involves Tyr102, Arg105, and other catalytically important residues on Loop S; this indicates that SuBKA is desuccinylated by SIRT5 probably through the catalytic mechanism proposed for peptide substrates. The biophysical and structural results presented herein will provide thermodynamic insights and key pharmacophore features for the development of selective sirtuin isoform-specific inhibitors.
机译:Sirtuins是烟酰胺腺嘌呤二核苷酸(NAD + )依赖的赖氨酸脱酰基酶,可调节代谢和应激反应,并参与人类病变,如神经退行性变。在这项研究中,合成了四种荧光小分子底物,即 ie ,乙酰基(AcBKA),巴豆酰基-(CrBKA),琥珀酰基-(SuBKA)和肉豆蔻酰基-(MyBKA)。并针对三种代表性的瑟土因异构体( ie ,SIRT2,SIRT5和SIRT6)进行了测试。酶动力学结果表明,与肽底物相比,荧光小分子底物具有类似的沉默调节蛋白同工型。 ITC分析表明,AcBKA或MyBKA与SIRT2的结合主要是由熵驱动的,而SuBKA与SIRT5的结合是由焓驱动的。 SIRT5:SuBKA复杂的晶体结构揭示了一种新的底物结合模式,该模式不同于肽底物结合模式,但涉及Loop S上的Tyr102,Arg105和其他催化重要的残基。这表明SuBKA可能是通过SIRT5被肽基底物催化的机制被去琥珀酰化的。本文提出的生物物理和结构结果将为开发选择性瑟土因异构体特异性抑制剂提供热力学见解和关键药效团特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号